Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	42	non-cytoplasmic
43	64	transmembrane
65	75	cytoplasmic
76	97	transmembrane
98	147	non-cytoplasmic
148	167	transmembrane
168	187	cytoplasmic
188	208	transmembrane
209	219	non-cytoplasmic
220	245	transmembrane
246	292	cytoplasmic
293	319	transmembrane
320	321	non-cytoplasmic
322	339	transmembrane
340	349	cytoplasmic
350	373	transmembrane
374	379	non-cytoplasmic
380	401	transmembrane
402	441	cytoplasmic

Input:
>BPHYT_RS16825 FitnessBrowser__BFirm:BPHYT_RS16825
MLKFFNSLFGRVVIALVAGIVVGAVFPHFAQSLRPLGDGFLKLIKMVIGPIVFCVVVSGM
AHAGDLRKVGRVGLKAVIYFEVMTTIALVIGAILAYVTRPGVGMNIDLHSLDPASLSTYT
EHAKSLKDTAGFLLKIIPDTAINAFATGDILQILVFSVLFGSALSLLGNKAQRVSSLIDE
LSQVFFRVMGFIIKLAPLGVLGAIAFTTGTYGVESLKQLGMLVLVFYLSCFVFVVVVLGV
VMRLAGFSIFKLIRYLREELSIVLGTASSDAVLPQIMRKLEWMGVKDSTVGLVIPTGYSF
NLDGFSIYLTLAVIFIAQATNTPLSVHDLIVVVLVSLVTSKGAHGIPGSAIVILAATLSA
IPAIPVLGLVLILPVDWFVGIARALTNLIGNCVATVVVAVWENDIDRARAHRVLNRDEAL
RYVPAGEDAEPAAAGEHAPAV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server